Abiraterone acetate for metastatic prostate cancer.
作者信息
Sonpavde Guru
机构信息
UAB Comprehensive Cancer Center, University of Alabama at Birmingham, 6th Avenue South, Birmingham, AL 35233, USA.
出版信息
Lancet Oncol. 2012 Oct;13(10):958-9. doi: 10.1016/S1470-2045(12)70392-3. Epub 2012 Sep 18.
Abstract
摘要
相似文献
1
Abiraterone acetate for metastatic prostate cancer.醋酸阿比特龙用于转移性前列腺癌
Lancet Oncol. 2012 Oct;13(10):958-9. doi: 10.1016/S1470-2045(12)70392-3. Epub 2012 Sep 18.
2
Abiraterone acetate for prostate cancer: a new era of hormonal therapies.醋酸阿比特龙用于前列腺癌：激素疗法的新时代。
Asian J Androl. 2011 Sep;13(5):663-4. doi: 10.1038/aja.2011.92. Epub 2011 Jul 11.
3
[Abiraterone acetate (AA): current guidelines of prescription of abiraterone].[醋酸阿比特龙（AA）：阿比特龙的当前处方指南]
Bull Cancer. 2014 Apr;101(4):388-93. doi: 10.1684/bdc.2014.1932.
4
Abiraterone acetate, a first-in-class CYP17 inhibitor, establishes a new treatment paradigm in castration-resistant prostate cancer.醋酸阿比特龙，一种首创的CYP17抑制剂，在去势抵抗性前列腺癌中建立了一种新的治疗模式。
Expert Rev Anticancer Ther. 2012 Jan;12(1):1-3. doi: 10.1586/era.11.196.
5
Effect of abiraterone acetate and prednisone compared with placebo and prednisone on pain control and skeletal-related events in patients with metastatic castration-resistant prostate cancer: exploratory analysis of data from the COU-AA-301 randomised trial.醋酸阿比特龙与泼尼松对比安慰剂与泼尼松在转移性去势抵抗性前列腺癌患者中对疼痛控制和骨骼相关事件的影响：来自 COU-AA-301 随机试验数据的探索性分析。
Lancet Oncol. 2012 Dec;13(12):1210-7. doi: 10.1016/S1470-2045(12)70473-4. Epub 2012 Nov 9.
6
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study.醋酸阿比特龙治疗转移性去势抵抗性前列腺癌：COU-AA-301 随机、双盲、安慰剂对照 3 期研究的最终总生存分析。
Lancet Oncol. 2012 Oct;13(10):983-92. doi: 10.1016/S1470-2045(12)70379-0. Epub 2012 Sep 18.
7
[CYP17A1 inhibitors in prostate cancer: mechanisms of action independent of the androgenic pathway].[CYP17A1抑制剂在前列腺癌中的作用：独立于雄激素途径的作用机制]
Prog Urol. 2013 Oct;23 Suppl 1:S9-15. doi: 10.1016/S1166-7087(13)70041-1.
8
Circulating tumour cells as surrogate biomarkers in castration-resistant prostate cancer trials.循环肿瘤细胞作为去势抵抗性前列腺癌试验中的替代生物标志物。
Eur Urol. 2011 Nov;60(5):905-7. doi: 10.1016/j.eururo.2011.08.024. Epub 2011 Aug 19.
9
Abiraterone in metastatic prostate cancer.阿比特龙用于转移性前列腺癌
N Engl J Med. 2013 Apr 11;368(15):1458-9. doi: 10.1056/NEJMc1301594.
10
Abiraterone in metastatic prostate cancer.阿比特龙用于转移性前列腺癌
N Engl J Med. 2013 Apr 11;368(15):1457. doi: 10.1056/NEJMc1301594.
Zotero 插件